| Autor: |
Karunakaran D; Cardiometabolic microRNA Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. d.karunakaran@imb.uq.edu.au.; Cardiac Function Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. d.karunakaran@imb.uq.edu.au.; Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia. d.karunakaran@imb.uq.edu.au., Turner AW; Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Duchez AC; Cardiometabolic microRNA Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Soubeyrand S; Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Rasheed A; Cardiometabolic microRNA Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Smyth D; Cardiac Function Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Cook DP; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Ontario, Canada., Nikpay M; Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Kandiah JW; Cardiometabolic microRNA Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Pan C; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Geoffrion M; Cardiometabolic microRNA Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Lee R; Cardiovascular Antisense Drug Discovery Group, Ionis Pharmaceuticals, Carlsbad, CA, USA., Boytard L; New York University Langone Medical Center, New York, NY, USA., Wyatt H; Cardiometabolic microRNA Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Nguyen MA; Cardiometabolic microRNA Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Lau P; Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Laakso M; Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland., Ramkhelawon B; New York University Langone Medical Center, New York, NY, USA., Alvarez M; Department of Human Genetics, and Institute for Precision Health, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Pietiläinen KH; Obesity Research Unit, Research Program for Clinical and Molecular Metabolism and Obesity Center, Endocrinology, Abdominal Center, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland., Pajukanta P; Department of Human Genetics, and Institute for Precision Health, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Vanderhyden BC; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Ontario, Canada., Liu P; Cardiac Function Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Berger SB; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Gough PJ; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Bertin J; Pattern Recognition Receptor DPU, GlaxoSmithKline, Collegeville, PA, USA., Harper ME; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada., Lusis AJ; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., McPherson R; Atherogenomics Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada., Rayner KJ; Cardiometabolic microRNA Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. krayner@ottawaheart.ca.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada. krayner@ottawaheart.ca. |
Full text from SpringerLink